Autonomix Medical Completes GLP Study for FDA Submission
THE WOODLANDS, Texas, August 12, 2026 Autonomix Medical, Inc. announced the successful completion of a Good Laboratory Practice (GLP)...
FDA Submission
Advertisement
Xeltis Raises €20.5M to Advance aXess and US Expansion
EINDHOVEN, The Netherlands, July 28, 2026 Xeltis has raised an additional €20.5 million in funding to accelerate the development...
Channel Robotics Raises $4.6M for Endoscopic Robotics
SAN DIEGO, June 18, 2026 Channel Robotics, a pioneering medical technology company developing a novel AI-enabled handheld endoscopic robotic...
Airiver Treats First Patient in Pivotal CRS Balloon Trial
BROOKLYN PARK, Minn., June 11, 2026 Airiver Medical has announced the successful treatment of the first patient in its...
Engitix and GSK Partner to Advance Liver Fibrosis Drug Discovery
London, UK – June 8, 2026 Engitix Ltd., a biotechnology company specializing in extracellular matrix (ECM)-driven drug discovery, has...
Advertisements
Lilly’s Foundayo Outperforms Rivals in Landmark Diabetes Trials
INDIANAPOLIS, USA – June 8, 2026 Eli Lilly and Company has reported compelling new Phase 3 clinical data showing...
J&J Files FDA Application for IMAAVY in wAIHA
February 24, 2026 – Spring House, Pennsylvania, USA Johnson & Johnson has announced the submission of a supplemental Biologics...
Levacetylleucine Phase III Success in A-T Trial
AUSTIN, Texas, Feb. 12, 2026 — IntraBio announced positive topline results from its pivotal Phase III IB1001-303 clinical trial...
FDA Review Begins for Motiva Implants in Breast Reconstruction
SAN JOSÉ, Costa Rica, Dec. 29, 2025 — Establishment Labs has submitted a regulatory application to the U.S. Food...
Lilly’s Oral GLP-1 Orforglipron Sustains Weight Loss in Phase 3 Trial
Indianapolis, December 18, 2025 — Eli Lilly and Company announced positive topline results from its first-of-its-kind Phase 3 ATTAIN-MAINTAIN...
Advertisement
